132 related articles for article (PubMed ID: 16784834)
1. Clinical outcome and service implications of screening women at increased breast cancer risk from a family history.
Gui GP; Kadayaprath G; Darhouse N; Self J; Ward A; A'Hern R; Eeles R
Eur J Surg Oncol; 2006 Sep; 32(7):719-24. PubMed ID: 16784834
[TBL] [Abstract][Full Text] [Related]
2. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
[TBL] [Abstract][Full Text] [Related]
5. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
6. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
7. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
8. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
9. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
10. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
[TBL] [Abstract][Full Text] [Related]
11. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
[TBL] [Abstract][Full Text] [Related]
12. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
14. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?
Gui GP; Hogben RK; Walsh G; A'Hern R; Eeles R
Eur J Cancer; 2001 Sep; 37(13):1668-73. PubMed ID: 11527694
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M
J Med Screen; 2002; 9(2):74-82. PubMed ID: 12133927
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Besnard PE; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Peterse H; Tilanus-Linthorst MM; Muller SH; Meijer S; Oosterwijk JC; Beex LV; Tollenaar RA; de Koning HJ; Rutgers EJ; Klijn JG;
N Engl J Med; 2004 Jul; 351(5):427-37. PubMed ID: 15282350
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
18. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
19. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
Randall D; Morrell S; Taylor R; Hung WT
Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
